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Summary
Unnatural combinations of polyketide synthase mod-
ules often fail to make a polyketide product. The
causes of these failures are likely complex and are
not yet amenable to rational correction. One possible
explanation is the inability of the ketosynthase (KS)
domain to extend the ketide donated to it by the up-
stream module. We therefore addressed the problem
by exchanging KS domains of the acceptor module
in a combinatorial fashion and coexpressing these
chimeric modules with ketide-donor modules that nat-
urally interact with the transplanted KS. This approach
was remarkably successful in activating previously
unproductive bimodular combinations, and the re-
sults augur well for the ongoing development of mo-
lecular tools to design and produce novel polyketides.
Introduction
Bacterial modular polyketide synthase (PKS) genes de-
termine the biosynthesis of valuable natural products
like erythromycin, epothilone, FK-506, and many others
[1]. They encode giant proteins consisting of sets (mod-
ules) of active sites (domains) that form an enzymatic
‘‘assembly line’’ to build the carbon chain of the final
product in a stepwise manner. The paradigm PKS gene
cluster for 6-deoxyerythronolide B synthase (DEBS),
which is responsible for 6-deoxyerythronolide B biosyn-
thesis, encodes a loading module followed by six ex-
tender modules. Polyketide synthesis is initiated when
the loading PKS module (LM) selects or generates the
starter acyl-CoA (propionyl CoA for DEBS) and transfers
its acyl group to the first of several extender modules. All
canonical extender modules contain at least a ketosyn-
thase (KS), acyl transferase (AT), and acyl carrier protein
(ACP) domains. The KS receives the acyl unit from the
preceding module, while the AT transfers an appropriate
extender unit from its CoA ester to the prosthetic group
of the ACP. The KS then catalyzes a decarboxylative
Claisen condensation between the acyl-KS and the
extender unit to give a b-keto-acyl-ACP. Modules may
also contain enzymes that further modify the growing
polyketide chain: notably, a set of reductases/dehydra-
tase for the b-keto group. The polyketide chain is suc-
cessively elongated by downstream modules and,
upon completion, is cleaved from the PKS—usually by
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San Francisco, California 94143.a thioesterase (TE) domain at its end [2]. Thus, the com-
ponents of each PKS module ‘‘encode’’ the structure of
the two-carbon unit in the main polyketide chain, the
order of modules determines the sequence of two-
carbon units in the polyketide product, and the number
of modules determines the carbon chain length. Be-
cause modules may be distributed over more than one
protein, both intra- and interpolypeptide acyl chain
transfers can occur, promoted by appropriate docking
domains to facilitate proximity [3, 4].
The modular nature of polyketide biosynthesis has fa-
cilitated genetic engineering of PKS genes to modify
polyketide structure. Because PKS modules comprise
natural, integrated catalytic units, rearranging intact
modules is an attractive approach for combinatorial bio-
synthesis [3]. In theory, this approach could generate
virtually any polyketide by combining modules with the
desired activities, but major challenges need to be
addressed. Success depends on each downstream KS
accepting the ketide from a donor module through an
unnatural intermodular junction, and this depends on
structural recognition of the ketide by the KS, physical
proximity of the ACP of the donor module and the
acceptor KS, and possible protein-protein interactions
between them. Carbon chain elongation then requires
substrate tolerance by and catalytic activity of the ac-
ceptor KS [5].
Because current knowledge is insufficient to rationally
design functional module-module interfaces a priori, we
approached the problem empirically by using combina-
torial biosynthesis [6]. The strategy was to make and
test large numbers of module-module combinations in
order to identify enough productive interfaces for as-
sembly of diverse, complex polyketides.
A combination of several technologies was necessary
to implement this approach. First, to avoid the compar-
ative inefficiency and inconvenience of working with ac-
tinomycetes and myxobacteria, the natural polyketide
producers, Escherichia coli was engineered to serve
as a host for polyketide production [7, 8]. Second, to ef-
fect rapid genetic manipulation, we developed a generic
design of PKS genes that involves optimizing codon
usage for E. coli expression and introducing a set of
standard unique restriction sites flanking catalytic do-
mains, docking domains, and modules to allow easy
interchange [6]. Third, technology was developed for
the facile synthesis of modules w5 kb-long containing
unique restriction sites, so that the redesigned PKS
genes could readily be obtained [9].
We also developed a two-plasmid system to rapidly
scan the ability of two heterologous PKS modules to in-
teract and produce polyketide [6]. The ‘‘donor’’ plasmid
contained the loading module of the erythromycin PKS
(LMery), followed by the diketide-donating module, and
terminated in the C-terminal docking domain from
eryM2 (LC—the second module of the erythromycin
PKS). The ‘‘acceptor’’ plasmid contained the eryM3 N-ter-
minal docking domain (LN), followed by the diketide-ac-
cepting module, and terminating in TEery (Figure 1A).
The plasmids were coexpressed in engineered E. coli
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470Figure 1. Expression Vectors and Cloning Scheme Used for Studying Effects of KS Domain Replacement
(A) The two compatible expression vectors used to test bimodular interactions. The pAng plasmids contain LMery followed by the donor mod-
ule and the C-terminal docking domain from eryM2 (LC). The pBru acceptor plasmids contain the N-terminal docking domain of eryM3 fol-
lowed by the acceptor module and TEery.
(B) Unique NdeI site at the start codon and KpnI site at the end of the KS domain of the synthetic modules used for KS exchange.strain K207-3 [8], and cultures were analyzed for the
expected triketide lactone product (TKL) by LC/MS/
MS. By creating libraries of modules in each of these
vectors, and by using combinatorial transformation [6],
we scanned over 150 module-module combinations for
activity, and, remarkably, 50% of the combinations pro-
duced the expected TKL. Since each module was active
in one or more contexts, we surmised that the problem
with the inactive unnatural module pairs could be the ab-
sence of an appropriate ACP-KS interaction, or inability of
the KS to catalyze the extension of a particular substrate.
The present work was undertaken to develop reliable
tools for converting inactive module-module interfaces
to active ones. In a few cases, an inactive module-mod-
ule interface has been activated by substituting the KS
domain of the ketide-accepting module by the KS that
is normally associated with the ketide-donating module
[10–12]. However, it is currently not possible to predict
whether a transplanted KS will accept and extend the
ketide, much less whether it will provide the product in
acceptable yield. We therefore embarked on a study in
which combinatorial biosynthesis was used to activate
inactive module pairs and optimize the yield of a desired
polyketide product by changing KS domains. We de-
scribe herein the results of these experiments, and pro-
vide an algorithm for ‘‘resuscitating’’ inactive hybrid
modular interfaces of PKSs and screening for those
that yield the most product.
Results and Discussion
Construction and Expression of Chimeric
PKS Modules
The previously reported [6] pBru acceptor expression
vectors used here contain synthetic ORFs encodingnine PKS modules—eryM1, eryM2, eryM3, eryM5,
eryM6, epoM7, sorM6, gdmM3, and rifM5—flanked by
the N-terminal docking domain of eryM3 at the 50 end,
and the DEBS TE at the 30 end, all under control of the
PBAD promoter. The ORFs were designed with a unique
NdeI site at the start codon and a unique KpnI site at co-
dons for the completely conserved GT dipeptide found
immediately downstream of the KS domain (Figure 1B)
[6]. The docking domain and KS domains of the 9
ORFs were then removed by NdeI/KpnI digestion and
replaced with the docking domain-KS fragments ob-
tained by NdeI/KpnI digestion of eryM2, eryM3, eryM5,
and eryM6, to produce 32 chimeric PKS modules with
heterologous KS domains. When the 9 ORFs with native
modules and the 32 hybrid ORFs were expressed from
the PBAD promoter at 22ºC in E. coliK207-3, all gave sim-
ilar levels of soluble protein in the range of 60–96 mg/l
(see Table S1 in the Supplemental Data). The high levels
of protein expression are undoubtedly due to the codon-
optimized PKS genes, which produce 5- to 10-fold more
PKS than wild-type sequences [13].
Activity of Modules Containing Natural
and Heterologous KS Domains
Extension of a diketide thioester by an acceptor module
requires: (1) substrate recognition and acylation of the
acceptor KS domain; (2) Claisen condensation between
the acyl-KS and the acyl-ACP of the same module; and
(3) modification of the b-keto group of the ketide chain
by the reduction/dehydration domains of the module.
In order to assess the intrinsic activity of individual
acceptor modules, module-TE fusions expressed in
E. coli K207-3 were treated with the (2S,3R)-2-methyl-
3-hydroxyhexanoic acid N-acetylcysteamine thioester
(SNAC) 1, and media were analyzed for production of
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471the expected TKL 2, 3, or 4 by LC/MS/MS (Figure 2A).
Additional products may be present in some cases,
but were not looked for, since the issue of potential
side products was beyond the scope of this work.
We used the diketide SNAC 1 derived from a butyryl
rather than the more common propionyl starter unit to
avoid ambiguities as to the origin of TKL products if
modules were capable of using MeMal-CoA for both
loading and iterative extension—a phenomenon re-
ferred to as ‘‘stuttering’’ [6, 14, 15]. That is, the TKL prod-
uct of stuttering cannot be distinguished from that
derived from the propionyl-diketide, whereas it is easily
differentiated by LC/MS/MS from that emanating from
the butyryl diketide SNAC 1. It has previously been
shown that propionyl-, butyryl-, and pentanoyl-diketide
SNACs are all effective in producing TKL products with
various PKS modules used here as sources for KS do-
mains [16–18].
As shown in Table 1, eryM2-TEery, eryM5-TEery, and
eryM6-TEery efficiently catalyze the conversion of 1
to provide the corresponding TKL 2, while eryM3-TE
converts the same SNAC to TKL 3. In contrast, although
eryM1 correctly extends propionic acid N-acetylcyste-
amine thioester [19], corresponding to its natural sub-
strate propionyl-CoA, it does not extend the diketide
moiety of 1 to the expected TKL product 4. Instead,
Figure 2. TKL Products Expected to Be Produced in this Study
(A) TKL products expected from the single extension of the SNAC 1
substrate by the modules used in this study.
(B) Structures of TKL products expected from the bimodular com-
binations.a small amount (0.8 mg/l) of the corresponding keto
lactone 3 is produced. Thus, the KS of eryM1 can accept
diketide 1 and catalyze the Claisen condensation, but
the KR of the module does not effectively reduce the
b-keto group of the extended diketide.
The KS domains of eryM2, eryM3, eryM5, and eryM6
were exchanged to explore the effects of interchanging
KSs among already functional modules (Table 1, col-
umns 2–5). SNAC 1 was fed to cultures expressing
each of the wild-type and chimeric modules, which are
predicted to produce TKL 2 from eryM2-, eryM5-, and
eryM6-TEs, and TKL 3 from eryM3-TE. In all cases, the
chimeric modules produced less TKL than the native
modules, although this reduction was less marked for
substitutions into the eryM3-TE module and the hybrid
of eryM5 containing eryM3 KS. Since the introduced
KSs accept the SNAC efficiently in their natural modules,
the lower yields obtained with the chimeric modules are
likely due to problems with the subsequent KS-cata-
lyzed Claisen condensation or unproductive interac-
tions resulting from KS-AT fusion junctions.
The KS of eryM1 was likewise exchanged for the KSs
from eryM2, M3, M5, and M6 that all appropriately ex-
tend the diketide component of SNAC 1 in their native
contexts. However, as with the KS in its native module,
the keto-lactone 3 was the sole TKL produced by
eryM1 chimeras with KSs originating from eryM2,
eryM3 or eryM6 (Table 1, column 1). Thus, as with the
natural KS of eryM1, KS hybrids of eryM1 accept and
extend the diketide moiety of SNAC 1, but do not appro-
priately reduce the b-carbon ketone.
Treatment of cells harboring unaltered epoM7-TEery,
sorM6-TEery, gdmM3-TEery, and rifM5-TEery with 1
gave low but detectable yields of the TKL product 2
(Table 2, top row). It is not surprising that the KSs of
these four modules process the diketide component of
1 poorly, since the (2S,3R)-ketide component of the
SNAC 1 does not resemble any of their natural sub-
strates [6]. It is also interesting to note that even though
the KR of epoM7-TE is suspected to be inactive [20],
epoM7-TE gave a product that, by LC/MS/MS, had iden-
tical mass, fragmentation pattern, and retention time as
an authentic standard of TKL 2, a result that has also
been previously observed [6]. Thus, it is quite reason-
able to conclude that the KR of epoM7-TE is active in
its present context.
Chimeras of the four poorly active modules, epoM7,
sorM6, gdmM3, and rifM5, were then examined. Each
native KS of these modules was substituted by theTable 1. Production, in mg/l, of Triketide Lactones 2 or 3 by Native and Chimeric Ery Module-Tes after Feeding with Diketide SNAC 1
Module-TE
KS Source (KSeryMx)-eryM1-TEa (KSeryMx)-eryM2-TEb (KSeryMx)-eryM3-TEc (KSeryMx)-eryM5-TEb (KSeryMx)-eryM6-TEb
KSeryM2 (0.05) 11d 19 0.1 0.01
KSeryM3 (0.4) —e 21d 1 2
KSeryM5 —e —e 16 3d —e
KSeryM6 (0.6) 0.01 14 0.01 21d
a Parenthesized yields are for unexpected keto-lactone 3 instead of expected TKL 4.
b Product is TKL 2.
c Product is keto-TKL 3.
d TKLs produced by wild-type module.
e No TKL detected; <0.01 mg/l.
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472Table 2. Production of Triketide Lactone 2, in mg/l, by Native and Chimeric Module-Tes after Feeding with Diketide SNAC 1
Module-TE
KS Source (KSeryMx)-epoM7-TE (KSeryMx)-sorM6-TE (KSeryMx)-gdmM3-TE (KSeryMx)-rifM5-TE
Native KS 0.1 0.02 0.03 0.01
KSeryM2 0.2 11 12 11
KSeryM3 —a 11 13 8
KSeryM5 0.08 0.9 0.01 0.01
KSeryM6 0.2 5 10 2
a No TKL detected; <0.01 mg/l.four KSs known to accept the diketide 1 (i.e., KSs from
eryM2, eryM3, eryM5, and eryM6) in an attempt to iden-
tify chimeric modules capable of extending the unnatu-
ral diketide substrate. Since none of the heterologous
KSs increased the efficiency of epoM7 (Table 2, col-
umn1), efforts were focused on the other three modules.
Substitution of the KS of sorM6 by eryM5 gave a 40-fold
increase in TKL production, but the eryM5 KS was in-
effective in other contexts studied (Table 2, row 4). Strik-
ingly, activities of modules derived from sorM6, gdmM3,
and rifM5 were dramatically increased by replacing their
KS domains with those from eryM2, eryM3, and eryM6
(Table 2, rows 2, 3, 5), with 160- to 1300-fold increases
in TKL yields over those of the natural modules. Indeed,
most chimeras created by KS exchange of the poorly ac-
tive sorM6-TE, gdmM3-TE, and rifM5-TE modules were
much more active than the native modules, and many
were about as efficient in extending the SNAC as the
most active native ery modules.
Activity of Bimodules with Active Chimeric
Modules as Acceptors
Having identified chimeric PKS modules derived from
sorM6, gdmM3, and rifM5 that showed good activity
when processing a chemically synthesized precursor,
we proceeded to determine whether these modules
would accept a substrate produced and offered by
appropriate upstream modules. For these experiments,
diketide-donating modules eryM1, eryM2, and eryM5,
which offer 2S,3R (eryM1) or 2R,3S (eryM2 and eryM5)
substrates to downstream modules, were flanked by
the ery LM on the N terminus and the LC on the C termi-
nus [6]. These pAng donor plasmids were coexpressed
with selected pBru acceptor plasmids containing
sorM6, gdmM3, and rifM5 with heterologous KS do-
mains, and TKL products were analyzed by LC/MS/MS
(Table 3). As shown previously, combinations of these
donor modules with sorM6, gdmM3, and rifM5 contain-ing their native KSs do not produce TKL [6]. In the pres-
ent work, the bimodular combinations tested were cho-
sen to maintain a cognate donor ACP-acceptor KS pair,
known to be functional in transfer of the donated sub-
strate (i.e., a 2S,3R or 2R,3S diketide) at the module-
module interface [6]. Thus, the LMery-eryM1 donor mod-
ule was coexpressed with the three chimeric acceptor
modules containing the KS from eryM2; the LMery-
eryM2 was coexpressed with the three chimeric mod-
ules containing the KS from eryM3; and LMery-eryM5
with the three chimeras containing the KS from eryM6.
The bimodular combinations involving LMery-eryM1
were tested for production of TKL 5, while those involv-
ing LMery-eryM2 and LMery-eryM5 were tested for the
presence of 6 (Figure 2B). Remarkably, all 9 combina-
tions were active, and each of the 3 inactive native mod-
ules was converted to at least 1 chimera that produced
relatively substantial yields (5–10 mg/l) of the expected
products (Table 2).
Significance
An algorithm has been established to resuscitate in-
active polyketide synthase (PKS) module-module in-
terfaces. First, the ketosynthase (KS) domain of the
substrate-accepting module-thioesterase (TE) is re-
placed by a library of KSs, normally downstream of
modules that will be used to donate the ketide. Sec-
ond, each member of the set of chimeras is tested for
intrinsic activity by feeding a diketide-SNAC resem-
bling the substrate made and presented by the donor
unit. This establishes the ability of the chimeric mod-
ule to accept and extend the substrate, isolated from
potential problems of interaction with the upstream
modules. Finally, the active modules are coexpressed
with the donor modules that are cognate with the KS
transplanted to the accepting module, and generation
of an active bimodular interface is demonstrated byTable 3. TKL Production by Bimodules Containing KS Substitutions in the Acceptor Module
Acceptor Modules
Donor
modules
[KSeryM2]
sorM6-TE
[KSeryM2]
gdmM3-TE
[KSeryM2]
rifM5-TE
[KSeryM3]
sorM6-TE
[KSeryM3]
gdmM3-TE
[KSeryM3]
rifM5-TE
[KSeryM6]
sorM6-TE
[KSeryM6]
gdmM3-TE
[KSeryM6]
rifM5-TE
LMery-eryM1a 4 8 4 — — — — — —
LMery-eryM2b — — — 10 5 3 — — —
LMery-eryM5b — — — — — — 0.6 1 0.2
Unfilled cells correspond to module pairs that do not contain cognate donor ACP and acceptor KS and were not tested.
a Product is TKL 5.
b Product is TKL 6.
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473production of the expected product. The feasibility of
this approach has been validated by resuscitating
nine bimodular variants involving three of four Mod-
TEs that were inactive in previously studied combina-
tions. The constructed chimeras not only gained the
ability to efficiently extend the diketide component,
SNAC 1, but gave excellent yields of triketide lactone
product (TKL) products when used as the acceptor
module in bimodular combinations. The activation of
hybrid modular interfaces by KS replacements pro-
vides a powerful tool to achieve the goal of generating,
to order, novel polyketides of potential value as drugs
or as synthons for making them.
Experimental Procedures
Host and Vectors
The E. coli polyketide production strain K207-3 (BL21DprpBCD::
T7prom prpE, T7prom accA1-pccB, T7prom sfp), as well as the
pAng plasmids containing LMery-Mod-LC with eryM1 (pKOS422-
108-1), eryM2 (pKOS422-99-2), or eryM5 (pKOS422-126-2), and the
pBru plasmids containing LN-Mod-TEery with eryM1 (pKOS422-
114-1), epoM7 (pKOS422-114-2), eryM5 (pKOS422-114-3), gdmM3
(pKOS422-114-4), rifM5 (pKOS422-114-6), eryM2 (pKOS422-
100-1), eryM6 (pKOS422-100-2), sorM5 (pKOS422-100-3), or eryM3
(pKOS422-177-1), have been previously described [6, 8].
Chimeric Plasmids
DNA manipulation procedures were performed as previously de-
scribed [21]. Fragments containing the 1.4 kb N-terminal docking
domain and KS domains were obtained by digestion of pBru plas-
mids with NdeI and KpnI, and purified by gel electrophoresis. Alter-
natively, the corresponding N-terminal docking domains and KS
domains to be replaced were removed from pBru plasmids contain-
ing LN-Module-TEery ORFs by digestion with NdeI and KpnI, and the
remainingw8.5 kb vector fragment was purified by gel electropho-
resis. Appropriate 8.5 and 1.4 kb fragments were then ligated to give
the hybrid expression plasmids containing a heterologous KS, and
the sequence of each construct was verified. The expression plas-
mids used in this study are listed in Table S2.
Diketide Feeding to Modules
K207-3 bacteria harboring pBru expression plasmids were grown in
2.5 ml LB with carbenicillin (50 mg/ml) at 37ºC to an OD600 = 0.5. Cul-
tures were induced with IPTG (0.5 mM) and arabinose (2 mg/ml), and
0.5 ml of a mixture of sodium glutamate (50 mM), sodium succinate
(50 mM), sodium propionate (5 mM), and (2S,3R)-2-methyl-3-
hydroxyhexanoic acid N-acetylcysteamine thioester 1 (1 mM) (2S,
3R-SNAC) [22] was added. After incubation at 22ºC for 72 hr with ag-
itation, bacteria were removed by centrifugation, and supernatants
were acidified with phosphoric acid to pH 2.5 and analyzed after
at least 30 min for TKL production by LC/MS/MS [6].
Protein Expression Analysis
Samples (1 ml) of each culture were centrifuged at 14,000 3 g for
3 min, resuspended in 1 ml 20 mM Tris, 150 mM NaCl, pH 7.5, and
lysed by sonication. After 10 min of centrifugation at 14,0003 g, sol-
uble fractions equivalent to 10 ml cell suspension were separated on
NuPAGE Novex 3%–8% Tris-acetate gels (Invitrogen), stained with
Sypro-Red Staining (Molecular Probes), and quantified with a
Typhoon scanner with BSA standards (Table S1).
Activity of Bimodular Combinations
K207-3 bacteria harboring pAng donor plasmids and pBru acceptor
plasmids were grown in 3 ml LB containing carbenicillin (50 mg/ml)
and streptomycin (20 mg/ml) at 37ºC to an OD600 = 0.5. Cultures
were induced with IPTG (0.5 mM) and arabinose (2 mg/ml), and
0.5 ml of a mixture of sodium glutamate (50 mM), sodium succinate
(50 mM), and sodium propionate (5 mM) was added. After 72 hr at
22ºC, cultures were processed as above and analyzed for TKL pro-
duction by LC/MS/MS [6].Quantification of Products by LC/MS/MS
TKL concentrations in samples were estimated by using calibration
curves developed for each TKL. Standards for TKLs 2, 5, and 6 were
prepared as previously described [16, 17, 23]. The identity of TKL 3
was verified by comparison of its product-ion scan (see Figure S1 in
the Supplemental Data) with that of the known propyl-analog [18]
and analysis, as previously described [24]. The TKL 3 standard
used for LC/MS quantitation was prepared by extending SNAC 1
with purified eryM3-TE [18]. To determine the concentration of the
TKL 3 standard, identical reactions were performed by using un-
labeled and [2-14C]methylmalonyl-CoA; the radioactive TKL was
separated and quantified by TLC with a Typhoon imager against
a standard curve of [2-14C]methylmalonyl-CoA, as previously de-
scribed [25].
Supplemental Data
Supplemental Data, including supplemental figure and tables, are
available online at http://www.chembiol.com/cgi/content/full/13/5/
469/DC1/.
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